TNF Pharmaceuticals (TNFA) Competitors $0.16 +0.01 (+5.92%) Closing price 04:00 PM EasternExtended Trading$0.16 +0.00 (+0.06%) As of 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsTrendsBuy This Stock TNFA vs. OBSV, IBIO, TSBX, AYTU, NKGN, CTXR, CPHI, PMCB, TRAW, and OMGAShould you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include ObsEva (OBSV), iBio (IBIO), Turnstone Biologics (TSBX), Aytu BioPharma (AYTU), NKGen Biotech (NKGN), Citius Pharmaceuticals (CTXR), China Pharma (CPHI), PharmaCyte Biotech (PMCB), Traws Pharma (TRAW), and Omega Therapeutics (OMGA). These companies are all part of the "pharmaceutical products" industry. TNF Pharmaceuticals vs. ObsEva iBio Turnstone Biologics Aytu BioPharma NKGen Biotech Citius Pharmaceuticals China Pharma PharmaCyte Biotech Traws Pharma Omega Therapeutics ObsEva (NASDAQ:OBSV) and TNF Pharmaceuticals (NASDAQ:TNFA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, community ranking, valuation, analyst recommendations, earnings, media sentiment, profitability, institutional ownership and dividends. Do institutionals & insiders believe in OBSV or TNFA? 17.5% of ObsEva shares are held by institutional investors. Comparatively, 9.6% of TNF Pharmaceuticals shares are held by institutional investors. 14.4% of ObsEva shares are held by company insiders. Comparatively, 1.2% of TNF Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community favor OBSV or TNFA? ObsEva received 319 more outperform votes than TNF Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformObsEvaOutperform Votes31949.53% Underperform Votes32550.47% TNF PharmaceuticalsN/AN/A Which has more risk and volatility, OBSV or TNFA? ObsEva has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, TNF Pharmaceuticals has a beta of 2.13, indicating that its stock price is 113% more volatile than the S&P 500. Is OBSV or TNFA more profitable? TNF Pharmaceuticals' return on equity of -180.71% beat ObsEva's return on equity.Company Net Margins Return on Equity Return on Assets ObsEvaN/A -416.36% -92.01% TNF Pharmaceuticals N/A -180.71%-84.27% Does the media prefer OBSV or TNFA? In the previous week, TNF Pharmaceuticals had 7 more articles in the media than ObsEva. MarketBeat recorded 8 mentions for TNF Pharmaceuticals and 1 mentions for ObsEva. TNF Pharmaceuticals' average media sentiment score of 0.07 beat ObsEva's score of 0.00 indicating that TNF Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ObsEva 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral TNF Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable valuation & earnings, OBSV or TNFA? TNF Pharmaceuticals has lower revenue, but higher earnings than ObsEva. TNF Pharmaceuticals is trading at a lower price-to-earnings ratio than ObsEva, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioObsEva$20.11M0.00-$58.38M-$0.92N/ATNF PharmaceuticalsN/AN/A-$4M-$6.67-0.02 SummaryTNF Pharmaceuticals beats ObsEva on 7 of the 12 factors compared between the two stocks. Get TNF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNFA vs. The Competition Export to ExcelMetricTNF PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.63M$2.63B$5.35B$8.44BDividend YieldN/A0.73%5.21%4.11%P/E Ratio-0.027.4826.9119.77Price / SalesN/A35.64390.06119.10Price / CashN/A15.7538.2534.62Price / Book0.025.486.794.52Net Income-$4M-$65.73M$3.23B$248.23M7 Day Performance-18.40%1.19%1.99%0.77%1 Month Performance-9.50%4.02%11.45%13.45%1 Year PerformanceN/A-15.64%17.35%7.67% TNF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNFATNF PharmaceuticalsN/A$0.16+5.9%N/AN/A$1.65MN/A-0.026Earnings ReportGap UpOBSVObsEvaN/AN/AN/AN/A$7.94M$20.11M-0.1150IBIOiBio1.1748 of 5 stars$0.79+2.3%$4.30+443.3%-67.1%$7.82M$375,000.000.00100High Trading VolumeTSBXTurnstone Biologics2.8575 of 5 stars$0.33-1.7%$0.45+34.7%-88.1%$7.73M$19.31M-0.1082Gap UpAYTUAytu BioPharma1.8271 of 5 stars$1.26+0.8%N/A-35.7%$7.71M$77.23M-0.87160NKGNNKGen BiotechN/A$0.28+61.4%N/A-85.8%$7.69M$80,000.00-0.05N/APositive NewsGap UpCTXRCitius Pharmaceuticals2.542 of 5 stars$0.78+4.1%$54.50+6,881.8%-96.3%$7.67MN/A0.0020Gap UpCPHIChina PharmaN/A$2.25+6.2%N/A-92.8%$7.34M$4.53M0.00250News CoverageAnalyst UpgradeGap DownPMCBPharmaCyte Biotech1.1797 of 5 stars$1.06-4.8%N/A-50.2%$7.26MN/A1.994Positive NewsGap DownTRAWTraws Pharma1.0044 of 5 stars$1.39+4.5%N/AN/A$7.09M$226,000.00-0.0117Earnings ReportGap UpOMGAOmega Therapeutics2.2977 of 5 stars$0.13-21.8%$9.20+7,260.0%-94.3%$6.92M$8.10M-0.09120News CoverageGap Up Related Companies and Tools Related Companies ObsEva Alternatives iBio Alternatives Turnstone Biologics Alternatives Aytu BioPharma Alternatives NKGen Biotech Alternatives Citius Pharmaceuticals Alternatives China Pharma Alternatives PharmaCyte Biotech Alternatives Traws Pharma Alternatives Omega Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNFA) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TNF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TNF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
